Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-centre, randomized controlled trial.

Naoki KimuraTakuya KawaharaYukari UemuraTatsuya AtsumiTakayuki SumidaToshihde MimuraYasushi KawaguchiHirofumi AmanoYukiko IwasakiYuko KanekoToshihiro MatsuiYoshinao MuroYoshitaka ImuraTakashi KandaYoshiya TanakaAtsushi KawakamiMasatoshi JinninTomonori IshiiKeiju HiromuraYusuke MiwaHiroshi NakajimaMasataka KuwanaYasuhiko NishiokaAkio MorinobuHideto KamedaHitoshi Kohsaka

Published in: Rheumatology (Oxford, England) (2022)

UMIN-CTR Clinical Trial, https://center6.umin.ac.jp/, UMIN000016233.

Keyphrases

phase ii
clinical trial
randomized controlled trial
open label
interstitial lung disease
study protocol
amino acid
phase iii
double blind
systemic sclerosis
rheumatoid arthritis
combination therapy